These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 38271343)
1. Exploring NCATS in-house biomedical data for evidence-based drug repurposing. Liu F; Patt A; Chen C; Huang R; Xu Y; Mathé EA; Zhu Q PLoS One; 2024; 19(1):e0289518. PubMed ID: 38271343 [TBL] [Abstract][Full Text] [Related]
2. Exploring NCATS In-House Biomedical Data for Evidence-based Drug Repurposing. Liu F; Patt A; Chen C; Huang R; Xu Y; Mathé EA; Zhu Q bioRxiv; 2023 Jul; ():. PubMed ID: 37546930 [TBL] [Abstract][Full Text] [Related]
3. The NCATS Pharmaceutical Collection: a 10-year update. Huang R; Zhu H; Shinn P; Ngan D; Ye L; Thakur A; Grewal G; Zhao T; Southall N; Hall MD; Simeonov A; Austin CP Drug Discov Today; 2019 Dec; 24(12):2341-2349. PubMed ID: 31585169 [TBL] [Abstract][Full Text] [Related]
4. Diversity, equity and inclusion actions from the NCATS Clinical and Translational Science awarded programs. Boulware LE; Vitale A; Ruiz R; Corbie G; Aguilar-Gaxiola S; Wilkins CH; Egede LE Nat Med; 2022 Sep; 28(9):1730-1731. PubMed ID: 35764682 [No Abstract] [Full Text] [Related]
5. Validating ADME QSAR Models Using Marketed Drugs. Siramshetty V; Williams J; Nguyễn ÐT; Neyra J; Southall N; Mathé E; Xu X; Shah P SLAS Discov; 2021 Dec; 26(10):1326-1336. PubMed ID: 34176369 [TBL] [Abstract][Full Text] [Related]
6. The National Center for Advancing Translational Sciences' Intramural Training Program and Fellow Career Outcomes. Haynes B; Brimacombe K; Hare C; Faupel-Badger J CBE Life Sci Educ; 2020 Dec; 19(4):ar51. PubMed ID: 33001768 [TBL] [Abstract][Full Text] [Related]
7. The US Federal Tox21 Program: A strategic and operational plan for continued leadership. Thomas RS; Paules RS; Simeonov A; Fitzpatrick SC; Crofton KM; Casey WM; Mendrick DL ALTEX; 2018; 35(2):163-168. PubMed ID: 29529324 [TBL] [Abstract][Full Text] [Related]
8. Areas of strength and opportunities for growth in translational science education and training: Results of a scoping review from the NCATS Education Branch. Vogel AL; Haynes BM; Hussain SF; Akacem LD; Hodges MG; Duberman JA; Butera G; Faupel-Badger JM Clin Transl Sci; 2023 Sep; 16(9):1526-1546. PubMed ID: 37533169 [TBL] [Abstract][Full Text] [Related]
11. Drug repurposing in rare diseases: Myths and reality. Fetro C; Scherman D Therapie; 2020 Apr; 75(2):157-160. PubMed ID: 32241561 [TBL] [Abstract][Full Text] [Related]
12. Repurposed Drugs as Potential Therapeutic Candidates for the Management of Alzheimer's Disease. Shoaib M; Kamal MA; Rizvi SMD Curr Drug Metab; 2017; 18(9):842-852. PubMed ID: 28595531 [TBL] [Abstract][Full Text] [Related]
13. CellMinerCDB: NCATS Is a Web-Based Portal Integrating Public Cancer Cell Line Databases for Pharmacogenomic Explorations. Reinhold WC; Wilson K; Elloumi F; Bradwell KR; Ceribelli M; Varma S; Wang Y; Duveau D; Menon N; Trepel J; Zhang X; Klumpp-Thomas C; Micheal S; Shinn P; Luna A; Thomas C; Pommier Y Cancer Res; 2023 Jun; 83(12):1941-1952. PubMed ID: 37140427 [TBL] [Abstract][Full Text] [Related]
14. [Data-driven drug discovery for drug repurposing]. Saito R; Yano N; Kojima S; Miyoshi F Nihon Yakurigaku Zasshi; 2023; 158(1):10-14. PubMed ID: 36596476 [TBL] [Abstract][Full Text] [Related]
15. Multiscale Virtual Screening Optimization for Shotgun Drug Repurposing Using the CANDO Platform. Hudson ML; Samudrala R Molecules; 2021 Apr; 26(9):. PubMed ID: 33925237 [TBL] [Abstract][Full Text] [Related]
16. Integrative rare disease biomedical profile based network supporting drug repurposing or repositioning, a case study of glioblastoma. McGowan E; Sanjak J; Mathé EA; Zhu Q Orphanet J Rare Dis; 2023 Sep; 18(1):301. PubMed ID: 37749605 [TBL] [Abstract][Full Text] [Related]
17. Keeping It Clean: The Cell Culture Quality Control Experience at the National Center for Advancing Translational Sciences. Roth JS; Lee TD; Cheff DM; Gosztyla ML; Asawa RR; Danchik C; Michael S; Simeonov A; Klumpp-Thomas C; Wilson KM; Hall MD SLAS Discov; 2020 Jun; 25(5):491-497. PubMed ID: 32233736 [TBL] [Abstract][Full Text] [Related]
19. Repurposing some of the Well-known Non-steroid Anti-inflammatory Drugs (NSAIDs) for Cancer Treatment. Sousa SM; Xavier CPR; Vasconcelos MH; Palmeira A Curr Top Med Chem; 2023; 23(13):1171-1195. PubMed ID: 36717997 [TBL] [Abstract][Full Text] [Related]
20. Challenges and recommendations for obtaining chemical structures of industry-provided repurposing candidates. Southan C; Williams AJ; Ekins S Drug Discov Today; 2013 Jan; 18(1-2):58-70. PubMed ID: 23159359 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]